This Analyst Thinks Sarepta (SRPT) Stock Can Go to $267
It’s a big day for Sarepta Therapeutics (NASDAQ:SRPT) investors. The company released positive preliminary results from …
Stay updatedRecent Headlines
3 Things to Know About Macy’s (M) Stock
By David Goodboy Retail is in trouble. With the ease of shopping on Amazon, endless choices …
How Crypto is Going Mainstream: itBit Licensed by NYDFS
By Jenny Lynton Crypto is gradually ‘starting to enter the mainstream financial services industry’ stated Neill …
A Balanced Take on Valeant (VRX) Following Yesterday’s Sell-Off
Valeant (NYSE:VRX) shares fell 12% yesterday on news that the FDA issued a complete response …
JD.com Stock Wins a Price Target Boost
Google announced yesterday that it will invest $550 million in Chinese e-commerce powerhouse JD.com (NASDAQ:JD), …
Healthcare Analysts Weigh in on Catalyst Biosciences’ (CBIO) Clinical Hold
Some investors might love biotech stocks for their lottery ticket-like returns when a company strikes …
Sarepta’s (SRPT) Gain Is Wave Life Sciences’ (WVE) Pain
Wave Life Sciences (NASDAQ:WVE) shares tumble nearly 14% in Tuesday’s trading session, following the news that competitor Sarepta …
Netflix (NFLX): Next Stop, $460?
Of all the widely followed and top-performing FANG stocks, Netflix (NASDAQ:NFLX) has shot the lights …
Top Rated AnalystsTop Analyst Insights
Netflix (NFLX): Next Stop, $460?
Of all the widely followed and top-performing FANG stocks, Netflix (NASDAQ:NFLX) has shot the lights …
This Top Analyst Stands Behind Micron (MU) Ahead Of Tomorrow’s Print
RBC Capital analyst Amit Daryanani is one of Micron’s (NASDAQ:MU) biggest bulls, and he is also …
Top Analyst Shines Light on Global Blood Therapeutic (GBT) Following Phase 2a Results in SCD
Global Blood Therapeutics (NASDAQ:GBT) investors got cold feet today, sending shares tumbling nearly 17%. The …
When Wall Street’s #1 Analyst Says Buy Nvidia (NVDA), You Should Listen
Nvidia (NASDAQ:NVDA) is riding the wave in technology sector strength. The stock jumped nearly 40% over …
The Bulls' CampLong Ideas
This Analyst Thinks Sarepta (SRPT) Stock Can Go to $267
It’s a big day for Sarepta Therapeutics (NASDAQ:SRPT) investors. The company released positive preliminary results from …
JD.com Stock Wins a Price Target Boost
Google announced yesterday that it will invest $550 million in Chinese e-commerce powerhouse JD.com (NASDAQ:JD), …
Netflix (NFLX): Next Stop, $460?
Of all the widely followed and top-performing FANG stocks, Netflix (NASDAQ:NFLX) has shot the lights …
Momo Inc: A Strong Buy Stock Millennial Investors Can’t Get Enough Of
Is your portfolio ready for “the world’s most important demographic”? This is a question that Bank …
The Bears' CampShort Ideas
Analyst Raises a New Red Flag on Tesla (TSLA)
Vertical Group analyst Gordon Johnson is out with another bearish note on shares of Tesla (NASDAQ:TSLA), …
Citron Bets Against Netflix (NFLX); Here’s Why
On March 12, 2018 when Netflix (NASDAQ:NFLX) was trading at $330, Citron suggested that the …
Short Opportunity: LexinFintech Holdings (LX)
The 180-day lockup period for LexinFintech Holdings (NASDAQ:LX) ends next Tuesday on June 19, 2018. When this …
General Electric (GE): EPG Conference Puts Bearish Risk Factor in the Spotlight, Says J.P. Morgan
J.P. Morgan’s Stephen Tusa sees GE Capital as an understimated risk, with the numbers pointing to another capital raise around the corner.
